Executive Team gp_j5unjv
Patrick M. O’Keefe, CPA/ABV/CFF, CTP, MAFFChief Executive Officer
Patrick O’Keefe has been responsible for the raising of debt and equity capital and is currently the CEO of Grow Michigan, a mezzanine fund supported by the Michigan Strategic Fund and sixteen financial institutions.
Sarabjit S. AshtaChief Business Officer
Sarabjit brings more than 20 years’ experience in the pharmaceutical industry and a proven record of success in growing businesses through external partnerships, in-licensing and M&A. Prior to joining Glycadia, he held leadership roles at Dr. Reddy’s Laboratories, Endo Pharmaceuticals, Biogen and Becton Dickinson which enabled him to create value-enhancing opportunities across a broad spectrum, including biopharmaceuticals, specialty pharmaceuticals, generics, medical devices and diagnostics. Sarabjit received his undergraduate degree in Econometrics from the London School of Economics and an MBA in International Finance from NYU Stearn School of Business.
Dr. Shearman is a Research and Development Executive with over 35 years of industry experience in the areas of molecular biology, immunology, oncology and endocrinology. He received a B.A. in Biology from the University of Virginia and a Ph.D. in Biochemistry from Thomas Jefferson University and Medical College. Before joining Glycadia, he was Research Director in Molecular Biology at Sterling Winthrop, Inc., a Group Leader in Protein Engineering at Genzyme Corporation, and a Senior Scientist in Molecular Biology at Centocor, Inc. He has over 60 scientific publications and 14 patent applications.
Dr. John BrennanChief Development Officer
Dr. Brennan is an accomplished pharma industry research and development scientist with over 35 years experience in all stages of endocrine, renal and respiratory drug development, regulatory affairs and lifecycle management. He directed multi-function global asset development teams and worked in bioanalytical assay development, drug metabolism and pharmacokinetics, clinical pharmacology, Phase I-IV clinical trials and global project management. He has also served as primary point-of-contact for pipeline governance, therapeutic area executive committees and external alliance partners. Dr. Brennan is a graduate of Temple University and received his Ph.D. in Pharmaceutical Sciences from The Philadelphia College of Pharmacy and Science. Before joining Glycadia he was a Senior Project Leader at AbbVie in the General Medicine Therapeutic Area, a Global Clinical Director in the Men’s Health and Women’s Health Therapeutic Area at Solvay Pharma, an Associate Medical Director in Clinical Pharmacology at Bristol-Myers Squibb. He has over 50 scientific publications and 2 patent applications.